Arteris Q1 2025 presentation highlights 28% revenue growth, strategic automotive wins

Published 13/05/2025, 21:24
Arteris Q1 2025 presentation highlights 28% revenue growth, strategic automotive wins

Introduction & Market Context

Arteris Inc. (NASDAQ:AIP), a provider of system-on-chip (SoC) interconnect intellectual property, presented its first quarter 2025 earnings results on May 13, showcasing strong financial performance and strategic customer wins. The company, which specializes in network-on-chip (NoC) interconnect IP, continues to build momentum in the automotive and artificial intelligence sectors, following the positive trends seen in previous quarters.

Led by CEO Charlie Janac and CFO Nick Hawkins (NASDAQ:HWKN), the presentation revealed significant year-over-year growth across key metrics, with particular strength in the automotive segment where the company secured multiple new design wins with major OEMs.

Quarterly Performance Highlights

Arteris reported impressive financial results for Q1 2025, achieving a record high of $66.8 million in Annual Contract Value (ACV) plus Royalties, representing a 15% increase year-over-year. Revenue reached $16.5 million, up 28% compared to the same period last year and exceeding the company’s guidance range of $15.7-$16.1 million.

As shown in the following comprehensive financial overview:

The company’s Remaining Performance Obligation (RPO) grew to $88.9 million, a 19% increase from Q1 2024, indicating a strong pipeline of future revenue. Non-GAAP gross profit reached $15.3 million with an impressive 92% margin, slightly higher than the 91% reported in both Q1 and Q4 2024.

Arteris highlighted several business achievements during the quarter, including continued success with top global technology companies, with four of the top 30 expanding their Arteris product deployments. The company also joined the Intel (NASDAQ:INTC) Foundry Accelerator program and IMEC-sponsored efforts around the Automotive Chiplet ecosystem scaling, positioning Arteris at the forefront of emerging semiconductor technologies.

Detailed Financial Analysis

Operating expenses and operating income showed improvement on a non-GAAP basis. While non-GAAP operating expenses increased by 8% year-over-year to $18.4 million, the company’s non-GAAP operating loss improved by 40% to $3.2 million compared to Q1 2024.

The detailed breakdown of operating metrics demonstrates this progress:

Particularly noteworthy was Arteris’ free cash flow generation of $2.7 million, a significant improvement from $0.3 million in Q1 2024 and a strong recovery from the negative $2.7 million reported in Q4 2024. This positive cash flow contributed to strengthening the company’s financial position, with cash, cash equivalents, and investments increasing to $55.1 million from $52.3 million in the previous quarter.

The following chart illustrates the company’s improving cash position:

Strategic Initiatives

Arteris made significant inroads in the automotive sector during Q1 2025, securing several strategic customer wins. A major Japanese automotive OEM licensed Arteris interconnect technology for in-house development of a new autonomous driving SoC, while an existing electric vehicle OEM customer expanded its use of Arteris products for another in-house developed SoC for its next generation of software-defined EVs.

Additionally, Nextchip licensed FlexNoC IP with AI and functional safety support for use in its next-generation vision-based Advanced Driver Assistance Systems (ADAS) technology, further cementing Arteris’ position in the automotive semiconductor market.

The company also expanded its global footprint by announcing a new engineering and customer support center in Krakow, Poland, enhancing its ability to serve European customers. On the product front, Arteris released the latest generation of its Magillem register management automation software, continuing its innovation in SoC design tools.

Forward-Looking Statements

Looking ahead, Arteris provided guidance for both Q2 and the full year 2025, projecting continued growth across key metrics. For Q2 2025, the company expects:

For Q2 2025, Arteris forecasts ACV plus Royalties of $66-$70 million (13% year-over-year growth at the midpoint) and revenue of $16.1-$16.5 million (12% year-over-year growth at the midpoint). The non-GAAP operating loss is expected to be between $4 million and $3 million, while free cash flow is projected between negative $5 million and $0.

For the full year 2025, Arteris anticipates ACV plus Royalties of $71-$79 million (15% year-over-year growth at the midpoint) and revenue of $65-$71 million (18% year-over-year growth at the midpoint). The company expects a non-GAAP operating loss between $14 million and $7 million for the year, with free cash flow projected between $0 and $8 million.

These projections suggest Arteris is on a path toward improved financial performance, with particular emphasis on revenue growth and cash flow generation, while continuing to invest in product development and market expansion.

In after-hours trading following the presentation, Arteris stock (NASDAQ:AIP) was down 5.75% to $7.87, despite the positive quarterly results and outlook, suggesting investors may have had higher expectations or were focusing on the continued operating losses despite their improvement.

Full presentation:

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.